• No results found

The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specific.

N/A
N/A
Info
Download
Protected

Academic year: 2019

Share "The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specific."

Copied!
9
0
0

Loading.... (view fulltext now)

Download now ( 9 Page )

Full text

Figure

FIG.2.coli(SEM)beforeblue.sequencesIPTG.mentleftExpression of gp86-specific fusion proteins in E
FIG. 3.fromataanitrocellulose a 1 Recognition of gp86 fusion proteins by human sera. gp86 fusion proteins (AP86 to NH86; see Fig
FIG. 6.dientstransferredcultureagainstatlularpp65noglobulins the Specificity of monoclonal antibody AP86-SA4
FIG. 8.gp86aminoproteins.aresite Linear antibody-binding site of glycoprotein gp86. The upper part shows the amino acid sequence of the amino-terminal region of from strains AD169 and Towne (bold letters)

References

Download now ( PDF - 9 Page - 2.17 MB )

Related documents

A Strain-Specific Epitope of Enterovirus 71 Identified by Cryo-Electron Microscopy of the Complex with Fab from Neutralizing Antibody

The monoclonal antibody MA28-7 neutralizes only specific strains of EV71 that have a conserved glycine at amino acid VP1-145, a surface-exposed residue that maps to the 5-fold

Human Cytomegalovirus Infection Elicits a Glycoprotein M (gM)/gN-Specific Virus-Neutralizing Antibody Response

The affinity-purified anti-gM/gN antibodies were reactive only with gM/gN transiently expressed in Cos-7 cells and nonreactive with transiently expressed gB, pp65, or pp150 in the

Broadly Neutralizing Antibodies Targeted to the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 Glycoprotein gp41

Mapping the protein surface of human immunodeficiency virus type 1 gp120 using human monoclonal antibodies from phage display libraries. Evaluation of monoclonal antibodies to

Development of an HSV 1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera

We established an HSV-1 neutralization test based on the enzyme-linked immunospot assay (ELISPOT-NT) to de- termine the neutralizing antibody titer against HSV-1 in human

Structure of a Neutralizing Antibody Bound Monovalently to Human Rhinovirus 2

The structure of a complex between human rhinovirus 2 (HRV2) and the Fab fragment of neutralizing monoclonal antibody (MAb) 3B10 has been determined to 25-Å resolution by

Neutralizing monoclonal antibodies that distinguish three antigenic sites on human cytomegalovirus glycoprotein H have conformationally distinct binding sites.

To map the epitopes within the various gH antigenic sites, we tested the panel of MAbs in neutralization assays with prototype HCMV strains Towne and Ad169 and with HCMV.

Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116).

Pulse-chase analysis of HCMV-infected cells was carried out, and the infected-cell proteins were precipitated with either monoclonal antibody 27-156 or 27-39 and the

Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits

Here we have cloned 113 human monoclonal antibodies (mAbs) specific for LASV glycoproteins from memory B cells of Lassa fever survivors from West Africa.. One-half bind the GP2